Pfizer, Inc. (PFE) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pfizer, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.058 Good day, everyone, and welcome to Pfizer's third quarter 2025 earnings conference 00:00:05.058 -- 00:00:08.923 call. Today's call is being recorded. 00:00:08.923 -- 00:00:13.449 At this time, I would like to turn the call over to Francesca DiMartino, Chief Investor 00:00:13.449 -- 00:00:16.352 Relations Officer and Senior Vice President. 00:00:16.352 -- 00:00:18.993 Please go ahead, ma'am. 00:00:19.076 -- 00:00:21.880 Good morning, and welcome to Pfizer's earnings call. 00:00:21.880 -- 00:00:25.625 I'm Francesca DiMartino, Chief Investor Relations Officer. 00:00:25.625 -- 00:00:28.752 On behalf of the Pfizer team, thank you for joining us. 00:00:28.752 -- 00:00:33.216 This call is being made available via audio webcast at Pfizer.com. 00:00:33.216 -- 00:00:38.041 Earlier this morning, we released our results for the third quarter of 2025 via a press 00:00:38.041 -- 00:00:42.104 release that is available on our website at Pfizer.com. 00:00:42.104 -- 00:00:48.230 I'm joined today by Dr. Albert Bourla, our chairman and CEO, and Dave Denton, our CFO. 00:00:48.230 -- 00:00:52.774 Albert and Dave have some prepared remarks, and we will then open the call for questions. 00:00:52.774 -- 00:00:57.254 Members of our leadership team will be available for the Q&A session. 00:00:57.254 -- 00:01:01.180 Before we get started, I want to remind you that we will be making forward-looking statements 00:01:01.180 -- 00:01:04.586 and discussing certain non-GAAP financial measures. 00:01:04.586 -- 00:01:08.573 I encourage you to read the disclaimers in our slide presentation, the press release 00:01:08.573 -- 00:01:13.581 we issued this morning, and the disclosures in our SEC filings, which are all available 00:01:13.581 -- 00:01:16.446 on the IR websit...